"Selling average of 20,000 shares per day" Odd I thought someone was buying 20,000 shares per day. Has it occured to anyone the people who took the credit swap know much more about the company then anyone posting here and according to Mel, they are selling.
Mel, I pointed out your misquoting me out of context before. Buying at $1.85 was "cheap" in comparison, but let's not forget he didn't have much choice on the last bail out. He could keep his below water investment and let freddie suck in a new investor, or he could take over and bounce freddie. He could have let it go into chapter 11 too.
I suggest the reason he bought was it was the best of a number of bad choices. I have written often, that I doubted Biolase will survive as an independent company. I assume Oracle thinks the pieces are worth more than $1.85 and hope they are worth $2.50.
I had no idea the US Navy could give them "international" sales.
Mel, "the "new" dragon tech? Exactly what part of the iLase is new and not base on decade old technology?
BTW, I think Oracle can put the company into bankruptcy and then sell the scraps to recover their investment. They are not emotionally tied to the company. I suspect any additional cash infusions will result in even more dilution for current share holders.
Hater? I prefer realist. But here goes. Although it is listed as a Section 4 "insider purchase" it is really emergency loan from the lender of last resort.
Feinberg and Oracle bought in originally at around $2.50. They knew the bank was calling in the loan. With no other cash source they had to decided whether to let Biolase go under, give freddie some more money and watch him burn it or buy more shares 30% cheaper than their original investment and try an salvage their original investment.
I wouldn't view this as a vote of confidence.
Mel, you are right: from tfiling: "Between December 13, 2012 and October 10, 2013, we sold an aggregate of $7,645,000 in principal amount of 5% subordinated convertible notes. The notes had a 5% annual interest rate and were convertible into our common stock at the rate of $0.23 per share (pre-split). The 2012 notes were scheduled to mature on December 31, 2015 and the 2013 notes were scheduled to mature on December 31, 2016. During the second and fourth quarters of 2013, one investor converted $1,500,000 in aggregate principal amount of notes into 6,521,739 shares (pre-split) of common stock. On March 31, 2014, all remaining investors converted the $6,145,000 outstanding aggregate principal amount of notes into 26,717,393 shares (pre-split) of common stock.
Two questions arise. First the post reverse split number of shares is roughly 3.3M shares. The total volume since the split is LESS than 210K.
How can these guys be "responsible for holding the price down?" and "Why would they sell if the stock is such a slam dunk?"
"BIOL is the one," "BIOL is the one," "BIOL is the one..."
No matter how often I say I can't see how a company that has lost $120M proving they can't sell their decade old technology at a profit is "the one." What research are you referring too? The continued HAND ASSEMBLY of their flagship product by minimum wage workers? The declining volume in real dollar sales of their flagship product? The padding of those sales with low margin OEM and handheld sales?
"earnings growth pattern now clearly established" There are no "earnings." There are reduced losses. But where have the sales come from? Once one wades through the flack one sees it is almost all from Navy contracts, EFOI's niche market, where they do not compete with the big boys. When one backs out those numbers one sees they are losing money in the commercial market they are touting.
EFOI will continue to make money selling to the Navy until one of the big boys decides it is a market worth having. Their MUCH lower cost of operation will swamp EFOI's boat. EFOI's shareholders biggest hope should be one of the big boys decides to buy EFOI at a premium to get the Navy contract instead of buying one of the other approved suppliers or getting approved on their own.
What makes you think EFOI will grow. They are a mouse with a marginal product in a field of elephants.
It would be nice, but how? Oracle is not a long term investor. IMHO, they are trying to buff up the numbers so they can get out somewhere near whole. That is completely possible in the short run. They just have to follow freddie's plan from the coup. they have already executed stage 1. Push all of the cost they can into 2Q and blame it on freddie, while delaying all of the bookings till 3Q13.
They realized the cno bank would lend to Biolase so they refinanced the minimum buying stock at the "market" price of $1.80, bringing their cost down and buying some time.
If they really believed in Biolase and were in it for the long term, they'd have brought in enough money to expanded to regional offices in big markets where relationships could be grown and service given. They would have revamped and automated he factory and INCREASED their sales force. They didn't. The question is, "Why?"
Mel, I am amused. The time stamp of your post was very close tot eh high for the day at $4.92. The price as I type is $4.52.
IMHO BIOL is a poor investment, but compared to EFOI its Boeing.
Mel, IMHO, BIOL has at best a 10% chance of surviving as an independent company for 2 years. I expect it will be sold as soon as Oracle can find a buyer. Is it possible Oracle finds a buyer willing to pay $3? Possible, yes, but unlikely, again IMHO.
As far as EFOI is concerned, IMHO as a person who designs lighting systems, there is no chance they will be in business five years from now. You only hope is that a major manufacturer opts to buy them for their Navy contract.
Mel, The first step to recovery is admitting the problem. Say it slowly, "freddie is a joke."
1.3M more shares added to the 7.5M already out. 17% dilution, but the stock is down 25% from this years high. The biger question is, "Will the company need addition financing in the next year or two?"
Doesn't look like the feud is settled. From freddie's PR
"Based upon his knowledge of quarterly sales and pending customer shipments as of mid-June, Mr. Pignatelli believes that current management deliberately manipulated the closing of sales that should have been recorded in the second quarter, and instead will record those sales in the third quarter. Doing so resulted in an artificially reduced net revenue figure for the second quarter of $10.2 million. With a $4 million decline in revenue compared with the prior-year second quarter, management orchestrated financial results..."
According to freddie I was right and Oracle revenue shifted to make freddie look bad and 3Q14 to look good.
I am SHOCKED. SHOCKED I tell you.
freddie refuses to go quietly:
"Based upon his knowledge of quarterly sales and pending customer shipments as of mid-June, Mr. Pignatelli believes that current management deliberately manipulated the closing of sales that should have been recorded in the second quarter, and instead will record those sales in the third quarter. Doing so resulted in an artificially reduced net revenue figure for the second quarter of $10.2 million. With a $4 million decline in revenue compared with the prior-year second quarter, management orchestrated financial results
WHAT? Revenue shifting has occurred!!!! Apparently you can't kid a kidder.
Remember how the Sunshine girls insisted freddie was completely on the up and up? Those same poster think Oracle is too.